A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients with Acquired Hypothalamic Obesity

What is the goal of the study?

To evaluate the efficacy of setmelanotide on change in body mass index (BMI)

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

• PI (Study Doctor): Christian Roth
• Study Team Member: ECR Endocrine Research, [email protected]